Road to recovery: How MSK conditions transformed advisers’ approach to benefits and care
This multi-part series explores the impact of MSK conditions, and the lessons benefit advisers learned as they sought treatment themselves.
This multi-part series explores the impact of MSK conditions, and the lessons benefit advisers learned as they sought treatment themselves.
In the first presidential debate of the 2024 election, President Joe Biden and former president Donald Trump faced off on important issues for employers and employees.
President Biden's Inflation Reduction Act is expected to save taxpayers an estimated $237 billion over the next decade.
Bipartisan support is building for allowing working Americans to purchase an individual health policy with pretax dollars without requiring an employer's permission.
Cancer is one of the top expense categories for employers, driven by inaccurate diagnoses, suboptimal treatment plans, expensive novel treatments and excess care. Solutions tend to be narrowly focused and miss the complex reality of an employee's cancer journey.
Definitive steps can be taken to strategically optimize pharmacy benefits in a way that balances cost with quality care.
The late Marshall Allen, an award-winning investigative journalist and book author, inspired legions of benefits professionals to seed better solutions.
Using pooled resources, expertise and a wide range of perspectives, brokers and advisers can create a voice louder than Big Pharma.
CEO of WellTheory Ellen Rudolph shares her journey to diagnosis and why it inspired her to start her company.
Rising costs and ever-changing employee needs mean that employers need to reconsider their health plan model.
They can be a more tax-effective way to save for retirement than an IRA for those who are able to max out contributions and pay for medical expenses with other funds.
Complex and rare diseases cost three to five times more than chronic conditions — a staggering employer cost that will reach trillions by 2030.
Supporting employees with a benefits plan that includes wellness and weight-loss options can create more than cost savings.
J&J allegedly mismanaged the company's prescription-drug benefits program, according to a lawsuit filed by an employee.
Reduce inpatient expenses through chronic condition management
No, they are not, but the good news is that new solutions are available.
Dr. Jayne Morgan, cardiologist and clinical director of the COVID task force at Piedmont Hospital in Atlanta, Georgia, reveals how racism plays a role in heart health.
Ellen Kelsay, CEO of Business Group on Health, and Eric Chaisson, SVP of total rewards at The Walt Disney Company, explain the significance of moving away from a traditional fee-for-service model.
Adi Gupta and Neha Patel, partners at Mckinsey and Company, break down what's in store for the healthcare industry in the next three years.
Dr. Nina Birnbaum, medical director of innovation acceleration at Blue Shield of California, explains how its virtual-first plan could expand access to quality care.